Investor Relations

Contact Us

Corporate Contact Investor Relations Human Resources General Inquiries

FINANCIAL RESULTS
QIAGEN reports results for fourth quarter and full year 2018
Open event
INFOGRAPHIC
Healthcare in 2025
OPEN
VIDEO
Explore our Video Hub
Visit Hub
Video Portal
video/mp4
NGS
The dawn of a new age
Read story
MICROBIOME RESEARCH
Behavior - it's all in our gut
Read Interview
TUBERCULOSIS
"Our goal is to develop easy and quick tests"
Read Interview

Latest press releases

SUBSCRIBE TO RSS-FEED

08.03.2019
QIAGEN and Tecan announce collaboration to streamline preanalytical processing of QuantiFERON-TB Gold Plus
READ MORE
06.03.2019
QIAGEN announces 20-F annual report filing for 2018 results
READ MORE
18.02.2019
QIAGEN partners with Ares Genetics to advance global fight against antibiotic-resistant pathogens
READ MORE
04.02.2019
QIAGEN reports results for fourth quarter and full-year 2018
READ MORE
04.02.2019
QIAGEN’s hereditary disease knowledge extended to NHS Genomic Medicine Service
READ MORE
16.01.2019
QIAGEN receives approval for EGFR test in lung cancer as companion diagnostic in Japan
READ MORE
14.01.2019
QIAGEN’s QuantiFERON®-TB Gold Plus gains approval in Canada
READ MORE
09.01.2019
QIAGEN provides status update on settlement mechanics of convertible notes
READ MORE
07.01.2019
QIAGEN launches QIAcube Connect – next-generation automation for sample processing in research labs
READ MORE
07.01.2019
QIAGEN acquires N-of-One, expanding its clinical bioinformatics capabilities in molecular oncology decision support
READ MORE

SEE ALL RELEASES

At a glance

Key figures teaser

Key figures

Strategy teaser

Strategy

IR - Share data teaser

Share data

Shareholder structure

Corporate calendar

SEE ALL EVENTS

Financial reports

SEE ALL REPORTS

Our social media channels

Visit our Social Hub

Do you have further questions?

FOLLOW US ON SOCIAL MEDIA

LANGUAGE

OTHER WEBSITES

© QIAGEN 2013 - 18. All rights reserved